The etiology and treatment of traumatic and septic shock

Comprehensive Therapy

Volumn 25, Issue 6-7, 1999, Pages 330-334

  Hardaway, Robert M ^a,b  

^a Texas Tech University Health Sciences Center El Paso   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR; TPA; UNCLASSIFIED DRUG;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; MULTIPLE ORGAN FAILURE; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; SEPTIC SHOCK; SWINE; TRAUMATIC SHOCK;

EID: 0032837759     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02944279     Document Type: Article

References (8)

1. Hardaway RM, McKay DG, Williams JH. Lower nephron nephrosis. Am J Surg. 1954;87:41-49.
2. Singer SN, Nicolson GL. The fluid model of the structure of cell membrane. Science. 1972;175:720.
3. Hardaway RM, Williams CH, Marvasti M, et al. Prevention of adult respiratory distress syndrome with plasminogen activator in pigs. Critical Care Med. 1990;18:1413-1418.
4. Hardaway RM, William CH, Sun Y. A new approach to the treatment of experimental septic shock. J Res. 1996;61;311-316.
5. Hardaway RM, Harke H, Williams CH. Fibrinogen agents: a new approach to the treatment of acute respiratory distress syndrome. Advanc Ther. 1994;11:43-51.
6. Hardaway RM, Johnson DG. Influence of fibrinolysis on shock. JAMA. 1963;183:597-599.
7. Hardaway RM, Drake DC. Prevention of irreversible hemorrhagic shock with fibrinolysis. Annals Surg. 1963;157:39-47.
8. Hardaway RM. A review of septic shock. The American Surgeon. In press.